Study details
Enrolling now
Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for Craniofacial Pain
Stanford University
NCT IDNCT04930887ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
15
Study length
about 7.4 years
Ages
18–80
Locations
1 site in CA
About this study
Researchers are testing whether endoscopically-guided injection of Exparel (Bupivacaine) can help treat craniofacial pain. The trial will involve a treatment with Exparel or saline, and it's designed to see if this approach provides relief compared to the usual topical application of Lidocaine.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Exparel (Bupivacaine Liposome)
- 2.Take Saline
PhasePhase 2
DrugBupivacaine Liposome
Routeinjection
Primary goalChange of Pain Score
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low7%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug routes
injection (Injection)
Endpoints
Primary: Change of Pain Score
Secondary: Change of Associated Symptoms
Body systems
Neurology